Multicenter, open-label, randomised, haloperidol-controlled study to evaluate Seroquel [quetiapine] as mono-therapy in the treatment of agitated symptoms in the patients with acute episode of schizophrenia

Trial Profile

Multicenter, open-label, randomised, haloperidol-controlled study to evaluate Seroquel [quetiapine] as mono-therapy in the treatment of agitated symptoms in the patients with acute episode of schizophrenia

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Aug 2012

At a glance

  • Drugs Haloperidol; Quetiapine
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Aug 2012 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
    • 02 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top